This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Contraindications

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

There are very few individuals who cannot receive MMR vaccine. When there is doubt, appropriate advice should be sought from a consultant paediatrician, immunisation co-ordinator or consultant in communicable disease control rather than withholding the vaccine.

The vaccine should not be given to:

  • those who are immunosuppressed
  • those who have had a confirmed anaphylactic reaction to a previous dose of a measles-, mumps- or rubella-containing vaccine
  • those who have had a confirmed anaphylactic reaction to neomycin or gelatin
  • pregnant women

Anaphylaxis after MMR is extremely rare (3.5 to 14.4 per million doses). Minor allergic conditions may occur and are not contraindications to further immunisation with MMR or other vaccines.

  • acute fever
    • if an individual is acutely unwell, immunisation should be postponed until they have fully recovered. This is to avoid confusing the differential diagnosis of any acute illness by wrongly attributing any signs or symptoms to the adverse effects of the vaccine

Reference:

  1. Immunisation Against Infectious Disease - "The Green Book".Chapter 21 Measles (April 2019)

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.